Pyrophosphate heart scan in patients with progressive systemic sclerosis

Area of Science:

• Cardiology
• Rheumatology
• Nuclear Medicine

Background:

• Systemic sclerosis frequently causes secondary myocardial involvement.
• Early detection of cardiac impairment is crucial for managing systemic sclerosis.
• Non-invasive imaging modalities are valuable for assessing cardiac function in these patients.

Purpose of the Study:

• To evaluate the utility of 99mTc-labelled pyrophosphate scintigraphy in detecting myocardial involvement in systemic sclerosis.
• To compare the sensitivity of pyrophosphate heart scintigraphy with electrocardiography and systolic time intervals.
• To explore potential correlations between cardiac and pulmonary involvement in systemic sclerosis.

Main Methods:

• 17 patients with systemic sclerosis underwent 99mTc-labelled pyrophosphate myocardial scintigraphy.
• Cardiac scan results were compared with electrocardiogram (ECG) findings and systolic time intervals.
• Spirometry was performed to assess pulmonary function.

Main Results:

• Pyrophosphate heart scintigraphy was positive in 7 out of 17 patients.
• ECG findings were abnormal in only 5 patients, and systolic time intervals were abnormal in 3.
• Ventilation disturbances were detected in 10 patients, with no clear relation to cardiac findings.

Conclusions:

• Pyrophosphate heart scintigraphy is a valuable tool for identifying myocardial impairment in systemic sclerosis, potentially preceding clinical heart failure.
• Systolic time interval examination has limited importance in assessing cardiac involvement in this condition.
• Further research is needed to understand the relationship between cardiac and pulmonary manifestations in systemic sclerosis.